Therapeutic Group: Respiratory Presentation Arofil 200 SR: Each film coated tablet contains Theophylline BP 200 mg in a sustained release formulation. Arofil 300 SR: Each film coated tablet contains Theophylline BP 300 mg in a sustained release formulation. Arofil 400 SR: Each film coated tablet contains Theophylline BP 400 mg in a sustained release formulation. […]
Therapeutic Group: Synthetic human parathyroid hormone analog Presentation TeripenTM: Each mL injectable solution contains teriparatide INN 250 mcg. Each cartridge is filled with 2.7 ml to deliver a 2.4 ml solution. Each cartridge, pre-assembled into a delivery device (Pen), delivers 20 mcg of teriparatide per dose each day for up to 28 days. Description Teripen […]
Therapeutic Group: Terbinafine Hydrochloride BP Presentation Mycocure 250 Tablet: Each tablet contains Terbinafine Hydrochloride BP equivalent to Terbinafine 250 mg. Description Terbinafine, an allylamine antifungal, inhibits biosynthesis of ergosterol, an essential component of fungal cell membrane, via inhibition of squalene epoxidase enzyme. This results in fungal cell death primarily due to increased membrane permeability mediated […]
Therapeutic Group: Urological Presentation Terazon 2: Each tablet contains Terazosin hydrochloride INN equivalent to Terazosin 2 mg. Terazon 5: Each tablet contains Terazosin hydrochloride INN equivalent to Terazosin 5 mg. Description Terazon (Terazosin hydrochloride) is a selective alpha-1 adrenoreceptor competitive blocking agent with a longer duration of action. Terazosin is a quinazoline derivative. It is […]
Therapeutic Group: Analgesic, Anti Inflammatory Presentation Tenopain: Each film coated tablet contains Tenoxicam BP 20 mg. Description Tenoxicam is a non-steroidal anti-inflammatory agent with analgesic and antipyretic properties. Tenoxicam is a potent inhibitor of prostaglandin synthesis by blocking the enzyme cyclo-oxygenase. Additional actions contributing to its anti-inflammatory effect includes inhibition of leukocyte functions including phagocytosis […]
Therapeutic Group: Anti Viral, Hepatitis B Medication Presentation Each tablet contains Tenofovir Disoproxil Fumarate INN 300 mg. Description Tenofovir Disoproxil Fumarate, an acyclic nucleotide analog of adenosine monophosphate, is a prodrug of Tenofovir. It shows activity against HBV polymerase and HIV reverse transcriptase after phosphorylation to the active diphosphate form. Tenofovir diphosphate inhibits viral polymerase […]
Therapeutic Group: Anti Viral, Hepatitis B Medication Presentation Alfavir : Each tablet contains Tenofovir Alafenamide INN 25 mg. Description Tenofovir Alafenamide, a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor, is converted into tenofovir, an acyclic nucleoside phosphonate (nucleotide) analog of adenosine 5′-monophosphate. Indications Tenofovir Alafenamide is indicated for the treatment of chronic hepatitis […]
Therapeutic Group: Cardiovascular Presentation Telmidip 40/5: Each tablet contains Telmisartan BP 40 mg and Amlodipine Besilate BP equivalent to Amlodipine 5 mg. Telmidip 80/5: Each tablet contains Telmisartan BP 80 mg and Amlodipine Besilate BP equivalent to Amlodipine 5 mg. Telmidip 40/10: Each tablet contains Telmisartan BP 40 mg and Amlodipine Besilate BP equivalent to […]
Therapeutic Group: Cardiovascular Presentation Telmipres Plus 40/12.5: Each tablet contains Telmisartan BP 40 mg & Hydrochlorothiazide BP 12.5 mg. Telmipres Plus 80/12.5: Each tablet contains Telmisartan BP 80 mg & Hydrochlorothiazide BP 12.5 mg. Telmipres Plus 80/25: Each tablet contains Telmisartan BP 80 mg & Hydrochlorothiazide BP 25 mg. Description Telmisartan blocks the vasoconstrictor and […]
Therapeutic Group: Cardiovascular Presentation Telmipres 20: Each tablet contains Telmisartan BP 20 mg. Telmipres 40: Each tablet contains Telmisartan BP 40 mg. Telmipres 80: Each tablet contains Telmisartan BP 80 mg. Description Telmisartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in […]